Documente Academic
Documente Profesional
Documente Cultură
of
LARVAE
-
PATHOLOGY
LIFE CYCLE
-
Diarrhea
Constipation
Vomiting
Abdominal cramps
Nausea
Fever
Pain and swelling
Weakness
Splenomegaly
Gastric and intestinal hemorrhages
Fever
Weakness
Pain
DIAGNOSIS
-
Muscle biopsy
Serological ELISA
TREATMENT
-
Capillaria philippinensis
-
EPIDEMIOLOGY
-
MORPHOLOGY
-
Unique feature
-
stool
and
become
embryonated
in
the
Host: humans
Intermediate host: freshwater and brackish
water fish
Role of intermediate host: site where the parasite
only develops before becoming infectious to the
primary host
Embryonation occurs in water only.
Unembryonated egg cannot be infectious.
Only embryonated egg is capable of infecting
humans because of its capacity to form larvae.
Prevalent in coastal areas
After embryonation, C. philippinensis egg is
ingested by the fish.
The infective intermediate host (fish) is ingested by
humans, goes to the systemic circulation, and the
cycle repeats.
OR, accidental host (birds) will ingest the fish.
CLINICAL FEATURES
-
lack
of
protein),
DIAGNOSIS
-
LABORATORY DIAGNOSIS
1.
-
2.
-
Stool analysis
Stools are bulky with elevated fecal fat content and
an average daily stool weight of 1200 g (versus
controls of 170 g).
Protein loss in the stools may be 15 times that seen
in controls.
Not a routine test in the lab, but can be done.
Egg
Still under stool analysis
Diagnostic characteristic
Length: 40 m x 20 m
Wuchereria bancrofti
Capillaria
philippinensis egg
TREATMENT
-
Hospitalization
Intake of fluids and electrolytes (especially, K
replacement)
High-protein diet
Antidiarrheal agents
Bancrofts filariasis
A blood and lymphatic dweller. The infection results
to elephantiasis (severe and disfiguring).
Vectors: Culex, Aedes and Anopheles mosquito
DIAGNOSIS
-
MORPHOLOGY
SPECIFIC TREATMENT
-
PREVENTION
-
LYMPHATIC FILARIASIS
-
MORPHOLOGY
larvae
LIFECYLE
2.
-
3.
-
and subsequently
TRANSMISSION
AND
INCUBATION
L1
1-3 hours
L2
3-4 days
L3
5-6 days
DIAGNOSTIC METHOD
1.
-
Penis
Legs
1.
-
2.
-
Breast
Selective treatment
For infected individuals
Drug: diethylcarbamazine citrate
Dosage: 6 mg/Kg body weight in 3 divided doses
for 12 consecutive days casually given after
meals
Mass treatment
Drugs are given to all population in endemic area
(2 y.o. and above).
Diethylcarbamazine citrate + albendazole
400 mg
Singe dose given anually
Prophylaxis for immunity